Clinical decision-support only. For use by licensed dental professionals. Not a substitute for professional judgment or a complete drug reference. Always verify with primary sources.
← Back to search
Medication

Tapentadol

Opioid analgesic (atypical) / norepinephrine reuptake

Brand names: Nucynta

Oral health effects

  • Xerostomia (dry mouth)

    Opioids reduce salivary flow; chronic use raises caries risk, compounded by sugary drinks and neglected hygiene.

    Clinical management: Hydration, salivary substitutes, high-fluoride caries prevention; screen for substance-use considerations.

  • Serotonergic/adrenergic interaction caution

    Has monoaminergic activity; caution with other serotonergic agents.

    Clinical management: Review interactions.

  • Dizziness or fainting on standing (orthostatic hypotension)

    The label warns that Tapentadol can cause severe hypotension, including orthostatic hypotension and syncope, in ambulatory patients; risk is higher with volume depletion or other CNS depressants/antihypertensives.

    Clinical management: Raise the chair slowly at the end of treatment, let the patient sit upright for a minute or two before standing, and assist them out of the chair; take extra care in older patients and those also on antihypertensives, sedatives or other CNS depressants.

Sources

  1. A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Wolff A, Joshi RK, Ekström J, et al. Drugs in R&D, 2017.
  2. Tapentadol prescribing information (FDA label) Collegium Pharmaceutical, Inc. / DailyMed, 2025.